Governments, Donors, Private Sector Should Prioritize Efforts To Address Global Pneumonia

Financial Times: Letter to the editor: Pneumonia is the single biggest killer of children in world’s poorest countries
Kevin Watkins, CEO at Save The Children U.K., and colleagues

“…Despite the relentless tide of fatalities, most governments are failing to prioritize pneumonia prevention and treatment. … [Governments] need not just to increase investment in under-financed health systems, but also increase the efficiency and equity of that investment. … Aid donors and pharmaceutical companies have a role to play. Development agencies should be attaching as much weight to pneumonia as they are to other killers, like malaria. That means supporting the development of national action plans to combat the disease, while building more effective public-private partnerships. Far more could be done through Gavi, the Vaccine Alliance, to lower the price and extend the reach of vaccines. We also believe aid donors and companies could be doing more to ensure that advances in diagnostic technologies and treatments reach the most disadvantaged children. Three years ago governments gathered with great ceremony to agree a set of 2030 development goals, including an end to preventable child deaths. They promised a focus on the most disadvantaged children. The ambition behind these pledges is laudable. But actions on pneumonia will speak louder than words” (2/6).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.